Commonwealth Equity Services’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.14M Buy
18,187
+12,044
+196% +$1.68M ﹤0.01% 1952
2025
Q4
$1.01M Sell
6,143
-42
-0.7% -$6.58K ﹤0.01% 2565
2025
Q3
$827K Sell
6,185
-35
-0.6% -$4.25K ﹤0.01% 2742
2025
Q2
$774K Sell
6,220
-397
-6% -$50.5K ﹤0.01% 2789
2025
Q1
$842K Buy
6,617
+389
+6% +$59.9K ﹤0.01% 2601
2024
Q4
$896K Sell
6,228
-92
-1% -$13.2K ﹤0.01% 2477
2024
Q3
$941K Sell
6,320
-219
-3% -$31.4K ﹤0.01% 2395
2024
Q2
$824K Sell
6,539
-321
-5% -$50.3K ﹤0.01% 2426
2024
Q1
$1.26M Sell
6,860
-352
-5% -$67K ﹤0.01% 2087
2023
Q4
$1.3M Sell
7,212
-1,127
-14% -$175K ﹤0.01% 1989
2023
Q3
$1.33M Sell
8,339
-64
-0.8% -$10.5K ﹤0.01% 1877
2023
Q2
$1.19M Sell
8,403
-204
-2% -$32.7K ﹤0.01% 1972
2023
Q1
$1.45K Sell
8,607
-48
-0.6% -$8.56K ﹤0.01% 1777
2022
Q4
$1.47M Sell
8,655
-80
-0.9% -$14.5K ﹤0.01% 1700
2022
Q3
$1.63M Buy
8,735
+20
+0.2% +$4.22K ﹤0.01% 1564
2022
Q2
$1.42M Sell
8,715
-112
-1% -$17.7K ﹤0.01% 1635
2022
Q1
$1.66M Sell
8,827
-2,638
-23% -$501K ﹤0.01% 1628
2021
Q4
$3.04M Sell
11,465
-727
-6% -$196K 0.01% 1215
2021
Q3
$3.52M Buy
12,192
+425
+4% +$109K 0.01% 1073
2021
Q2
$2.35M Sell
11,767
-2,565
-18% -$498K 0.01% 1319
2021
Q1
$2.79M Buy
14,332
+2,749
+24% +$564K 0.01% 1105
2020
Q4
$2.22M Buy
11,583
+1,051
+10% +$191K 0.01% 1171
2020
Q3
$1.55M Buy
10,532
+222
+2% +$31.7K 0.01% 1235
2020
Q2
$1.27M Buy
+10,310
New +$1.21M ﹤0.01% 1276
2016
Q2
Sell
-12,210
Closed -$327K 2288
2016
Q1
$327K Sell
12,210
-811
-6% -$19.8K ﹤0.01% 1579
2015
Q4
$368K Buy
13,021
+177
+1% +$5.1K ﹤0.01% 1466
2015
Q3
$358K Sell
12,844
-302
-2% -$10.9K ﹤0.01% 1446
2015
Q2
$543K Buy
13,146
+3,282
+33% +$120K 0.01% 1290
2015
Q1
$299K Buy
+9,864
New +$256K ﹤0.01% 1640
2014
Q3
Sell
-9,207
Closed -$210K 2132
2014
Q2
$210K Buy
+9,207
New +$164K ﹤0.01% 1793

Other funds holding RGEN

Commonwealth Equity Services's RGEN Position: Q1 2026 in Review

Commonwealth Equity Services increased its Repligen (RGEN) stake by 196% in Q1 2026, buying an estimated $1.68M and bringing the position to 18,187 shares worth $2.14M. The position accounts for ﹤0.01% of the portfolio, ranked #1952.

Commonwealth Equity Services first reported a position in RGEN in Q2 2014 and has held it in 30 quarters since. The position peaked at $3.52M in Q3 2021. 441 funds tracked by Wall St. Rank hold RGEN as of Q1 2026.

  • Commonwealth Equity Services held 18,187 shares of Repligen worth $2.14M as of Q1 2026.
  • Commonwealth Equity Services bought 12,044 Repligen shares in Q1 2026, an estimated $1.68M.
  • Repligen made up ﹤0.01% of Commonwealth Equity Services's portfolio in Q1 2026, its #1952 holding.
  • Commonwealth Equity Services first reported a position in Repligen in Q2 2014 and has held it in 30 quarters since.
  • Commonwealth Equity Services's Repligen position peaked at $3.52M in Q3 2021.
  • 441 funds tracked by Wall St. Rank held Repligen as of Q1 2026.

Based on Commonwealth Equity Services's 13F filing for Q1 2026, filed 27 Apr 2026.